Poloxamers are vital nonionic surfactants used in pharmaceutical formulations, where their composition directly impacts performance and functionality. Regulatory compliance, as defined in the USP-NF and Ph. Eur. monographs, requires Nuclear Magnetic Resonance (NMR) analysis to ensure product consistency and quality.
Image Credit: Bruker Biospin
The Bruker Fourier 80 benchtop NMR spectrometer offers an ideal platform for this type of testing. Compact and cryogen-free, it fulfills all technical requirements of the monographs and is specifically designed to meet the practical needs of Quality Control laboratories.
Bruker’s GxP kits, built on years of industry experience, further support full regulatory compliance without compromising on usability or automation capabilities.
Download the full whitepaper here.
About Bruker BioSpin - NMR, EPR and Imaging - Pharma
Welcome to Bruker BioSpin and the world's most comprehensive range of NMR and EPR spectroscopy and preclinical imaging research tools. The Bruker BioSpin Group of companies develop, manufacture and supply technology to research establishments, commercial enterprises and multi-national corporations across countless industries and fields of expertise.
Bruker BioSpin is continuing to revolutionize the design, manufacture and distribution of life science, preclinical, process control and analytical research tools based on magnetic resonance and multimodal imaging technologies. Bruker BioSpin is the worldwide technology and market leader in magnetic resonance technologies (NMR, EPR) and offers the largest portfolio of imaging modalities for preclinical and industrial research under a single brand.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.